M&A Strategy
Selective by Nature,
Decisive by Conviction
Acquisition Philosophy
We Do Not Pursue Every Opportunity.
We Pursue the Right Ones.
Our process is deliberately unhurried. We study industries, build relationships over years, and wait for moments when we can acquire exceptional businesses at prices that reflect long-term reality rather than short-term sentiment.
We look for companies with durable competitive advantages, strong management teams, and the potential for meaningful value creation under our stewardship — not financial engineering.
Target Deal Size
€25M – €500M EV
Preferred Ownership
Majority or full control
Investment Horizon
7–15 years
Return Threshold
20%+ IRR
Focus Areas
Target Sectors
Industrial & Manufacturing
Precision manufacturers, niche industrial suppliers, and engineered components with defensible market positions.
View Detail →
Technology & Software
B2B software, SaaS platforms, and technology-enabled services with recurring revenue and high switching costs.
View Detail →
Healthcare Services
Specialty healthcare, diagnostics, and medical devices serving aging populations and under-penetrated markets.
View Detail →
Financial Services
Specialty finance, insurance, and wealth management businesses in regulated but fragmented markets.
View Detail →
Consumer & Retail
Premium consumer brands and retail networks with genuine pricing power and loyal customer bases.
View Detail →
Real Estate & Infrastructure
Commercial real estate and infrastructure assets with long-term contracted cash flows.
View Detail →
Industrial & Manufacturing is the platform's core focus — the majority of our capital, underwriting, and operating capability is dedicated to industrial businesses. The remaining sectors are pursued selectively, where our industrial underwriting and value-creation capabilities apply directly.
Value Creation Model
How We Create Enduring Value
01
Proprietary Sourcing
Relationships built over decades enable access to off-market opportunities before they reach broader auction processes.
02
Deep Diligence
Our teams conduct exhaustive operational, financial, and strategic analysis — never relying on sell-side materials alone.
03
Active Ownership
We work closely with management teams on strategy, governance, talent, and capital allocation — as true partners.
04
Patient Exit
We realise value at the right moment through the right channel — IPO, strategic sale, or continuation — never under pressure.